Adverse drug reaction (ADR) reporting in India: a long way to go

Authors

  • Anant D. Patil Freelance consultant: Medical communication and training

Keywords:

Adverse drug reaction, India, Pharmacovigilance

Abstract

New drugs are regularly introduced for treatment, diagnosis or prevention of diseases. Adverse drug reactions (ADR) can be seen in clinical practice with both new as well as marketed medicines. Spontaneous reporting of ADR is commonly practiced method for monitoring of ADR. Healthcare practitioners have an important role in pharmacovigilance and ADR reporting. Many studies have been conducted to understand the knowledge, attitude and practice of ADR reporting among healthcare practitioners in India. The population surveyed in these studied ranged between 90-1200. One large study4 included population of 1200 physicians across India out of which 1000 were contacted for study participation.

References

Joshi SR, Sapatnekar SM. Pharmacovigilance in India: How safe are the new drugs? How sure are we? JAPI. Dec 2008; 56: 933-934.

Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011 Oct-Dec; 2;4:129-136.

Chopra D, Wardhan N, Rehan HS. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital. The International Journal of Risk and Safety in Medicine. 2011;23(4):227-232.

Kharkar M and Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspect Clin Res. 2012 Jul-Sep; 3; 3: 90–94.

Rehan HS, Sah RK, Chopra D. Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital. Indian J Pharmacol. 2012 Nov-Dec; 44; 6: 699–703.

Pimpalkhute SA, Jaiswal K M, Sontakke S D, Bajait C S, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci 2012;66:55-61

Hardeep, Bajaj JK, Kumar R. A Survey on the Knowledge, Attitude and the Practice of Pharmacovigilance Among the Health Care Professionals in a Teaching Hospital in Northern India. Journal of Clinical and Diagnostic Research. 2013 January; 7; 1: 97-99.

Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. J Nat Sci Biol Med. 2013 Jan-Jun; 4; 1: 191–196.

Santosh KC, Tragulpiankit P, Gorsanan S, Edwards IR. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol toxicol. 2013;14:16.

Perez GM, Figueras A. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals. Pharmacoepidemiol Drug Saf. 2011;12:1295-302.

Downloads

Published

2017-02-02

How to Cite

Patil, A. D. (2017). Adverse drug reaction (ADR) reporting in India: a long way to go. International Journal of Basic & Clinical Pharmacology, 2(6), 846–848. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1383

Issue

Section

Letter to the Editor